Acute treatment with desipramine stimulates melatonin and 6‐sulphatoxy melatonin production in man.

Authors:
  • CFC Franey
    C Franey
  • MAM Aldhous
    M Aldhous
  • SBS Burton
    S Burton
  • SCS Checkley
    S Checkley
  • JAJ Arendt
    J Arendt

Abstract
Acute administration of the antidepressant drug desipramine (DMI) in man, increased evening melatonin secretion, which reached peak plasma levels 2‐4 h earlier than after placebo administration. The increase at set time points 21.00 h‐22.00 h was directly proportional to an individual's integrated night‐time secretion of melatonin. We have shown that this stimulation was not an effect of DMI inhibition on the hepatic metabolism of melatonin to 6‐sulphatoxy melatonin (aMT6s), indeed aMT6s is in itself a good index of the evening melatonin rise. The stimulation of early evening melatonin by DMI might be exploited as a simple pineal function test.

This publication has 25 references indexed in Scilit: